Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Ketteler

Showing results (151-160 of 220) with videos related to

Pageof 22
Sort By:
Annals of Internal Medicine|May 19, 2010
The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul StudyBenjamin D Parker, Leon J Schurgers, Vincent M Brandenburg, et al.
Blood Purification|September 25, 2007
Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation indexMarc M H Hermans, Cees Vermeer, Jeroen P Kooman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 10, 2010
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerabilityAngel L M de Francisco, Michael Leidig, Adrian C Covic, et al.
Plos One|May 10, 2018
Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcificationMiguel D Ferrer, Markus Ketteler, Fernando Tur, et al.
Clinical Kidney Journal|February 10, 2021
Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcificationAntonio Bellasi, Paolo Raggi, Jordi Bover, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 27, 2004
Characteristics and performance of an immunosorbent assay for human matrix Gla-proteinLeon J Schurgers, Kirsten J F Teunissen, Marjo H J Knapen, et al.
Clinical Kidney Journal|September 29, 2015
Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet)Vincent Brandenburg, Teresa Adragao, Bastiaan van Dam, et al.
The Journal of Clinical Endocrinology and Metabolism|August 2, 2020
Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1-84)Kristina S Chen, Elvira O Gosmanova, Gary C Curhan, et al.
American Journal of Nephrology|May 3, 2013
Determinants of fibroblast growth factor-23 and parathyroid hormone variability in dialysis patientsTing Jia, Abdul Rashid Qureshi, Vincent Brandenburg, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 11, 2012
Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathyRafael Kramann, Vincent M Brandenburg, Leon J Schurgers, et al.
Pageof 22

Showing results (151-160 of 220) with videos related to

Sort By:
Pageof 22
Annals of Internal Medicine|May 19, 2010
The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul StudyBenjamin D Parker, Leon J Schurgers, Vincent M Brandenburg, et al.
Blood Purification|September 25, 2007
Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation indexMarc M H Hermans, Cees Vermeer, Jeroen P Kooman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 10, 2010
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerabilityAngel L M de Francisco, Michael Leidig, Adrian C Covic, et al.
Plos One|May 10, 2018
Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcificationMiguel D Ferrer, Markus Ketteler, Fernando Tur, et al.
Clinical Kidney Journal|February 10, 2021
Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcificationAntonio Bellasi, Paolo Raggi, Jordi Bover, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 27, 2004
Characteristics and performance of an immunosorbent assay for human matrix Gla-proteinLeon J Schurgers, Kirsten J F Teunissen, Marjo H J Knapen, et al.
Clinical Kidney Journal|September 29, 2015
Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet)Vincent Brandenburg, Teresa Adragao, Bastiaan van Dam, et al.
The Journal of Clinical Endocrinology and Metabolism|August 2, 2020
Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1-84)Kristina S Chen, Elvira O Gosmanova, Gary C Curhan, et al.
American Journal of Nephrology|May 3, 2013
Determinants of fibroblast growth factor-23 and parathyroid hormone variability in dialysis patientsTing Jia, Abdul Rashid Qureshi, Vincent Brandenburg, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 11, 2012
Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathyRafael Kramann, Vincent M Brandenburg, Leon J Schurgers, et al.
Pageof 22